Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001828316-24-000039
Filing Date
2024-12-16
Accepted
2024-12-16 06:02:20
Documents
2
Period of Report
2024-12-15

Document Format Files

Seq Description Document Type Size
1 6-K pharmingannouncespubliccas.htm 6-K 109242
2 logo_greyxoriginalxa.jpg GRAPHIC 115057
  Complete submission text file 0001828316-24-000039.txt   256385
Mailing Address DARWINWEG 24 LEIDEN P7 2333 CR
Business Address DARWINWEG 24 LEIDEN P7 2333 CR 31 (0)71 5247 400
Pharming Group N.V. (Filer) CIK: 0001828316 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39822 | Film No.: 241550008
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)